Navigation Links
Study Suggests Invega Helps Patients With Schizophrenia Maintain,,,Symptom Control

tolerability for INVEGA in the treatment of patients with schizophrenia. In this study, participants were treated with flexible doses of INVEGA (3mg to 15mg once daily, with 9mg as the starting dose) after concluding their previous double-blind study treatment. The study population was segmented into three subgroups based on treatment experience during the previous six-week trials: placebo to INVEGA; INVEGA to INVEGA; and olanzapine to INVEGA.

Because there were more INVEGA active treatment groups in the short-term efficacy trials, most patients entering this OLE study had previously received short-term treatment with INVEGA. Patient groups receiving INVEGA in the short-term efficacy trials were shown to have significantly improved by the end of short-term treatment when they became eligible to enter the OLE study, both in symptoms and in functioning, compared to placebo. In total, 47 percent of patients completed the longer-term 52-week OLE study.

Efficacy analyses included change from baseline to end point in Positive and Negative Syndrome Scale (PANSS)* total score and the Personal and Social Performance (PSP)** scale, a measure of personal and social functioning.


    EFFICACY ASSESSMENTS



    PANSS



    - Improvements in PANSS total score in all treatment groups were observed



      over the first 12 weeks of the OLE study and were maintained throughout



      the remainder of the 52-week trial



    - Mean PANSS total scores improved from open-label baseline most notably



      in patients in the placebo-to-INVEGA group





    PSP Scale



    - The improvements seen in patient personal and social functioning during



      the six-week placebo-controlled trial, were maintained over the 52-week



      period.



"The pooled efficacy data suggest to me that long-term treatment with INVEGA helps to sustain symptom control and social function
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:1/23/2015)... Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) ... of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... its fiduciary duties to shareholders. On January ... website reporting that Advaxis had misrepresented the clinical data ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... N.J. and LACHEN, Switzerland, Sept. 26, 2011 ... largest human protein products manufacturers in the world, has ... efficacy and safety of wilate® (von Willebrand ... post-operative bleeding in pediatric and adult patients with Type ...
... Accuray Incorporated (Nasdaq: ARAY ), the premier ... to present at the JMP Securities Healthcare Conference in New ... a.m. PDT. A live webcast of the presentation ... the Company,s website at http://www.accuray.com . The webcast replay ...
Cached Medicine Technology:Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 2Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 3
(Date:1/22/2015)... Glendale, AZ (PRWEB) January 22, 2015 Padre ... a long supporter of Pro Player Health Alliance ... with Padre Murphy's in getting everyone, including NFL greats, treated ... one of the leading groups supporting the cause in the ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Jan. 16 John T. Gribbin of Clarksburg, president ... was installed as chairman of the board of the ... The chairman,s official installation, as well as the appointment ... Annual Meeting at the Hyatt Regency Princeton. "Here in ...
... 16 The Endovascular Forum, Inc. (EVF), an ... of Interventional Radiology (SIR) announce a collaboration that ... Communities of Practice (CoP) goals of reconstructing clinical ... to enhance clinical performance and diagnostic and procedural ...
... Inc. (LPI) announced today that it has received ... Application (ANDA) for Levetiracetam Tablets 250mg, 500mg, 750mg ... Administration (USFDA). Commercial shipments of the product ... equivalent of UCB Pharmaceuticals, Keppra(R) tablets, indicated as ...
... Lung Cancer Partnership is pleased to announce I-Ching Wang, ... of the 2009 Career Development Award. , The $80,000 grant ... develop their careers in lung cancer research. , ... protein that binds to specific parts of DNA and plays ...
... health insurance market increasingly becomes consumer-driven, BlueCross BlueShield of ... insurance with face-to-face assistance at the company,s first retail ... Mount Pleasant, S.C.Located at 615 Johnnie Dodds Blvd., Suite ... the 1,800 square foot SC BlueStore(SM) will ...
... Ind., Jan. 16 Hill-Rom Holdings,Inc.,s, (NYSE: HRC ... February 4, 2009. You are invited to participate in ... a.m. EST. , Earnings Release: ... ended December 31, 2008 will be released to the public,after ...
Cached Medicine News:Health News:Hospital Association Names New Chairman, Appoints Board Officers and New Members 2Health News:The Endovascular Forum, Inc. and the Society of Interventional Radiology Partner to Extend the Clinical Influence of Electronic Medical Care Advancement Through Communities of Practice Designed to Deepen the Conversation of Clinical Experience and Advance 2Health News:The Endovascular Forum, Inc. and the Society of Interventional Radiology Partner to Extend the Clinical Influence of Electronic Medical Care Advancement Through Communities of Practice Designed to Deepen the Conversation of Clinical Experience and Advance 3Health News:The Endovascular Forum, Inc. and the Society of Interventional Radiology Partner to Extend the Clinical Influence of Electronic Medical Care Advancement Through Communities of Practice Designed to Deepen the Conversation of Clinical Experience and Advance 4Health News:Lupin is Granted USFDA Approval for Levetiracetam Tablets 2Health News:S.C. BlueCross to Open Its First Health Insurance Retail Store 2Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast 2
... The Hoffmann® II Hybrid External ... the next generation in hybrid fixation. ... trauma surgeons and is designed to ... our exclusive patented Hoffmann® snap-fit technology. ...
... individual components for individual indications. XCaliber covers ... of an innovative composite plastic material, XCaliber ... lighter. This means it's easier to handle, ... the patient. ,Come pre-assembled, packaged sterile, and ...
The Hybrid Fixator consists of Three basic components: rings, wires, clamps. Final fracture reduction can be easily performed after frame assembly....
... associated with displaced pelvic fractures is one ... orthopaedic and trauma surgeons. , ,Recognizing the ... external fixation, and internal fixation in these ... been developed as a method to provide ...
Medicine Products: